Page last updated: 2024-11-01

nilvadipine and Hypertrophy, Right Ventricular

nilvadipine has been researched along with Hypertrophy, Right Ventricular in 2 studies

Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.

Research Excerpts

ExcerptRelevanceReference
"The severe right ventricular hypertrophy observed in untreated rats was significantly reduced in drug treated animals."1.29Contrasting effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on calcium transients in isolated rat cardiac myocytes. ( Enomoto, K; Hashimoto, M; Honda, M; Kuramochi, T; Mansoor, AM; Morioka, S; Tanaka, K, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, K2
Honda, M2
Kuramochi, T2
Hashimoto, M2
Masumura, S1
Mansoor, AM2
Ishikawa, S1
Morioka, S2
Enomoto, K1

Other Studies

2 other studies available for nilvadipine and Hypertrophy, Right Ventricular

ArticleYear
Different effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on protein metabolism in rats with right ventricular hypertrophy.
    Journal of hypertension, 1994, Volume: 12, Issue:10

    Topics: Absorptiometry, Photon; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers;

1994
Contrasting effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on calcium transients in isolated rat cardiac myocytes.
    Cardiovascular research, 1994, Volume: 28, Issue:9

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Calcium Channel Blockers; Cells, Culture

1994